EXE.TO Extendicare Inc.

Extendicare Announces February 2023 Dividend of C$0.04 per Share

Extendicare Announces February 2023 Dividend of C$0.04 per Share

MARKHAM, Ontario, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of February 2023, which is payable on March 15, 2023 to shareholders of record at the close of business on February 28, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services to a network of 103 long-term care homes and retirement communities (53 owned/50 contract services), provide approximately 9.2 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 107,000 beds across Canada. Extendicare proudly employs approximately 19,000 qualified, highly trained and dedicated individuals who are passionate about providing high quality care and services to help people live better.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions “anticipate”, “believe”, “estimate”, “expect”, “intend”, “objective”, “plan”, “project”, “will”, “may”, “should” or other similar expressions or the negative thereof. These forward-looking statements reflect the Company’s current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at and on Extendicare’s website at

Extendicare contact:

Jillian E. Fountain

Vice President, Investor Relations

T: (905) 470-5534

E:



EN
15/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Extendicare Inc.

 PRESS RELEASE

Extendicare Acquires Nine Long-Term Care Homes from Revera

Extendicare Acquires Nine Long-Term Care Homes from Revera MARKHAM, Ontario, June 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare”) (TSX: EXE.TO) announced today that, effective June 1, 2025, it has completed the previously announced transaction with Revera Inc. and certain of its affiliates to acquire nine “Class C” long-term care homes (the “Acquired Homes”) located in Ontario and Manitoba and one parcel of vacant land located in Ontario (the “Transaction”). The consideration for the Transaction was approximately $60.3 million, comprised of $40.2 million in cash and the ass...

 PRESS RELEASE

Extendicare Announces Voting Results for its 2025 Annual and Special M...

Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2025 (the “Meeting”). The voting results for each of the matters considered at the Meeting are presented below.  The total number of common shares represented by shareholders present in person or by proxy at the Meeting was 47,282,730, representing 56.41% of the Company’s ...

Extendicare Inc: 1 director

A director at Extendicare Inc sold 65,000 shares at 14.607CAD and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Extendicare Announces 2025 First Quarter Results

Extendicare Announces 2025 First Quarter Results MARKHAM, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2025. First Quarter 2025 Highlights Adjusted EBITDA(1) excluding out-of-period items increased by $8.7 million or 42.7% to $29.0 million, driven by improvements across all three business segments.5.0% dividend increase to 4.2 cents per month.Home health care average daily volume (“ADV”) increased to 31,603, an increase of 8.9% from Q1 2024.SGP third-party and joint vent...

 PRESS RELEASE

Extendicare Announces Agreement to Acquire Closing the Gap Healthcare ...

Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), has entered into an agreement to acquire all of the issued and outstanding shares of Closing the Gap Healthcare Group Inc. and certain affiliates (collectively, “Closing the Gap”) from the ultimate shareholders of Closing the Gap (the “Transaction”). Closing of the Transaction is sub...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch